| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |